Get the Stockscreener App
26.17
0.76%
-0.20
Surrozen Inc stock is traded at $26.17, with a volume of 50,599.
It is down -0.76% in the last 24 hours and down -7.00% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
See More
Previous Close:
$26.37
Open:
$26.54
24h Volume:
50,599
Relative Volume:
0.51
Market Cap:
$303.84M
Revenue:
$7.49M
Net Income/Loss:
$-360.50M
P/E Ratio:
-0.6333
EPS:
-41.3227
Net Cash Flow:
$-33.68M
1W Performance:
+2.35%
1M Performance:
-7.00%
6M Performance:
+59.14%
1Y Performance:
+228.58%
1-Day Range:
$25.72
$27.00
1-Week Range:
$25.00
$27.87
52-Week Range:
$7.45
$35.00
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
26.17 | 306.17M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | TD Cowen | Buy |
| Feb-19-26 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
View All
Surrozen Inc Stock (SRZN) Latest News
Number of shareholders of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Q1 2026 Earnings: Staggering EPS Miss of -$11.65 Versus Estimate; Stock Declines 2.66%Non-GAAP Earnings - Newser
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Reflects Ongoing Clinical-Stage Spending; No Revenue ReportedEarnings Growth Forecast - Newser
Surrozen Inc. (SRZN) Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock Edges HigherCommunity Watchlist Picks - Newser
What Does TCG Crossover GP II's Recent Buying Spree Mean for Surrozen (SRZN) - Kavout
Surrozen (SRZN) director and 10% owner receives options on 5,550 shares - Stock Titan
Surrozen (SRZN) major holder The Column Group discloses stakes up to 29.3% - Stock Titan
Surrozen (SRZN) Q1 2026 Results Miss Estimates — EPS $-11.65 vs $-1.11Top Trending Breakouts - Newser
We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate - Yahoo Finance
How (SRZN) Movements Inform Risk Allocation Models - Stock Traders Daily
Surrozen (SRZN) Drops -5.76% — Key Support at $26.74 2026-05-17Live Trade Sharing - Newser
SRZN Price Today: Surrozen, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Nantahala, Harkey & Mack report 225,772 SRZN shares (2.14%) — SRZN - Stock Titan
Venrock-led group reports 9.99% stake in Surrozen (SRZN) - Stock Titan
Chen Yu and TCG Funds Report 1.47M SRZN Shares (SRZN) - Stock Titan
5AM entities disclose 9.5% stake in Surrozen (NASDAQ: SRZN) and contingent shares - Stock Titan
[SCHEDULE 13G] Surrozen, Inc./DE Passive Investment Disclosure (>5%) - Stock Titan
Surrozen (SRZN) joint filing shows 525,639-share position, 4.5% stake - Stock Titan
Surrozen (SRZN) Q3 2025 Earnings: Miss Sparks ConcernElite Trading Signals - newser.com
Surrozen (SRZN) director receives 5,550 stock options at $30.14 strike - Stock Titan
Surrozen (SRZN) grants director David Woodhouse 5,550 stock options - Stock Titan
Surrozen Shareholders Support Board, Auditor and Pay Policies - TipRanks
Surrozen (SRZN) director awarded 5,550 options at $30.14 exercise price - Stock Titan
Director Christopher Chai gets 5,550 Surrozen (SRZN) stock options - Stock Titan
Surrozen (SRZN) director receives 5,550 stock options at $30.14 strike price - Stock Titan
Surrozen (SRZN) director receives grant of 5,550 stock options - Stock Titan
Surrozen (SRZN) investors approve directors, auditor and annual say-on-pay - Stock Titan
TradingKey - TradingKey
SRZN: All agenda items passed, including director elections and annual advisory votes on compensation - TradingView
Surrozen to Present at Upcoming Healthcare Investor Conference - The Manila Times
Eye disease biotech Surrozen joins H.C. Wainwright investor forum - Stock Titan
SRZNW Surrozen quarterly update shows clinical progress but no revenue as pipeline development continues.Global Trading Community - Newser
Lifesci Capital Has Strong Forecast for Surrozen Q2 Earnings - MarketBeat
HC Wainwright Estimates Surrozen's Q2 Earnings (NASDAQ:SRZN) - MarketBeat
The key driver behind Surrozen (SRZN) revenue growth | Q3 2025: EPS Misses ViewsMargin Compression - newser.com
Surrozen (SRZN) Q1 Loss Of US$127.5 Million Reinforces Bearish Community Narratives - Sahm
Surrozen, Inc. Q1 2026 Quarterly Report Highlights Financial Results, Risk Factors, and Key Developments - Minichart
Surrozen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Surrozen (NASDAQ: SRZN) books $127.5M loss as derivatives drive volatility - Stock Titan
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update - Investing News Network
Surrozen (SRZN) posts Q1 2026 loss as PIPE liabilities surge - Stock Titan
Surrozen keeps eye-drug candidate on track for H2 2026 FDA filing - Stock Titan
Trading Systems Reacting to (SRZN) Volatility - Stock Traders Daily
Surrozen’s exec. VP Li Yang sells $52,799 in shares By Investing.com - Investing.com Nigeria
Surrozen CEO Craig Parker sells $150,797 in company stock By Investing.com - Investing.com Nigeria
Surrozen’s exec. VP Li Yang sells $52,799 in shares - Investing.com
Surrozen CEO Craig Parker sells $150,797 in company stock - Investing.com
Surrozen (SRZN) EVP sells shares to cover RSU tax withholding - Stock Titan
Surrozen (SRZN) COO exercises 5,625 RSUs, sells 2,036 shares for taxes - Stock Titan
Surrozen (NASDAQ: SRZN) CEO exercises RSUs, sells shares to cover taxes - Stock Titan
SRZN (Surrozen) posts far larger than projected Q3 2025 loss, while shares rise amid positive investor sentiment.Revenue Breakdown - Newser
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):